FIELD: medicine, gastroenterology, pharmacy.
SUBSTANCE: invention relates to a pharmaceutical composition used in treatment of changed gastroenteric contracting capability. The composition comprises tegaserod and co-agent taken among the group including prucaloprid, fluoxetine, fedotosine, baclofen, octreotide, omeprazol and ranitidine. The combination provides attainment of synergetic effect.
EFFECT: improved and valuable medicinal properties of composition.
7 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW COMPOSITION FOR ORAL ADMINISTRATION | 1999 |
|
RU2260424C9 |
| APPLICATION OF METHYL NALTREXONE FOR TREATING IRRITABLE COLON SYNDROME | 2004 |
|
RU2373936C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING PARTIAL 5HTAGONIST | 2002 |
|
RU2322978C2 |
| HUMAN GROWTH HORMONE SECRETION STIMULANTS | 2006 |
|
RU2416612C9 |
| PHARMACEUTICAL COMBINATION COMPRISING IBAT-INHIBITOR AND BILE ACID BINDER | 2011 |
|
RU2619215C2 |
| METHODS AND COMPOSITIONS FOR TREATING GASTROINTESTINAL DISORDERS | 2004 |
|
RU2543350C2 |
| METHODS AND COMPOSITIONS FOR GASTROENTERIC UPSET THERAPY | 2004 |
|
RU2353383C2 |
| GASTROINTESTINAL STIMULATOR | 2006 |
|
RU2395300C2 |
| ACID PUMP ANTAGONIST FOR TREATING DISEASES ASSOCIATED WITH PATHOLOGICAL IMPAIRMENT OF GASTROINTESTINAL MOTILITY | 2010 |
|
RU2586276C2 |
| PHENYLOXALAMIDES, METHODS FOR PRODUCTION THEREOF AND USE THEREOF AS MEDICINAL AGENT | 2008 |
|
RU2488578C2 |
